Log In
Print
BCIQ
Print
Print this Print this
 

IV carbamazepine (Carbella)

  Manage Alerts
Collapse Summary General Information
Company H. Lundbeck A/S
DescriptionSodium channel blocker
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy; Treat epilepsy in patients who cannot take oral medication
Regulatory Designation U.S. - Orphan Drug (Treat epilepsy in patients who cannot take oral medication);
U.S. - Standard Review (Treat epilepsy in patients who cannot take oral medication)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$900.0M

$600.0M

$300.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today